Serum placental-like alkaline phosphatase levels and nicotine intake in smokers
1988

Serum Alkaline Phosphatase Levels and Nicotine Intake in Smokers

Sample size: 753 publication Evidence: moderate

Author Information

Author(s): G.A. Ellard, D.F. Tucker, Y.L. Pookim, D.Y. Wang, R.D. Barlow, R.B. Stone

Primary Institution: National Institute for Medical Research, Imperial Cancer Research Fund, Medical College of St Bartholomew's Hospital

Hypothesis

What is the relationship between cigarette smoke intake and serum placental-like alkaline phosphatase levels?

Conclusion

The study found significant correlations between serum PLAP-like AP levels and nicotine intake from smoking.

Supporting Evidence

  • There was a progressive increase in serum PLAP-like AP levels with higher reported cigarette consumption.
  • Significant correlations were found between serum PLAP-like AP levels and urinary nicotine metabolite excretion.
  • Biochemically proven smokers showed similar significant correlations.

Takeaway

Smokers have higher levels of a specific enzyme in their blood, which can help us understand how smoking affects health.

Methodology

The study measured serum and urine samples from smokers to assess levels of PLAP-like AP and nicotine metabolites.

Potential Biases

There may be bias in self-reported smoking status, as some participants denied smoking despite biochemical evidence.

Limitations

The study relied on self-reported smoking habits, which may not always be accurate.

Participant Demographics

Normal women aged 35 years or more from Guernsey.

Statistical Information

P-Value

<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication